LongeVC | Latest News & Updates - Apr 16, 2025 Release
Dr. John Mikhael joins LongeVC's advisory board on April 14, 2025, enhancing focus on AI-driven diagnostics and Boston-based innovation...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡
LongeVC
🌎 longevc.comLongeVC is a venture capital firm based in Lugano, Switzerland, founded in 2016. The company specializes in supporting early-stage biotech and longevity-focused founders, helping them gain industrial momentum, raise capital, and shape the future of the biotech industry. LongeVC aims to build a broad community of biotech innovators by funding companies in complementary sectors and facilitating collaboration among them.
LongeVC - Latest News and Updates
- Dr. John Mikhael joins LongeVC's advisory board on April 14, 2025, enhancing focus on AI-driven diagnostics and Boston-based innovation.
- LongeVC has added Dr. John Mikhael, a computational neuroscientist and medtech founder, to its scientific advisory board.
- Aurora Griffin from LongeVC will speak at the A4LI D.C. Summit on April 28-30 about extending the healthy human lifespan.
- LongeVC will support and participate in the ARDD 2025 event in Copenhagen from August 25-29, featuring Managing Partners Sergey Jakimov and Garri Zmudze, and Head of Advisory Board Alex Zhavoronkov.
Sign up to receive regular updates
If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.
